Iguana Healthcare Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Iguana Healthcare Management’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$477K	Hold	150,000	–	–	0.31%	59
2017 Q4	$615K	Sell	150,000 -200,000	-57%	-$870K	0.4%	56
2017 Q3	$1.58M	Sell	350,000 -50,000	-13%	-$203K	0.86%	41
2017 Q2	$1.33M	Sell	400,000 -90,000	-18%	-$373K	0.75%	43
2017 Q1	$4.51M	Sell	490,000 -60,000	-11%	-$527K	2.23%	13
2016 Q4	$4.24M	Sell	550,000 -900,000	-62%	-$8.27M	2.53%	13
2016 Q3	$16.6M	Buy	1,450,000 +817,800	+129%	+$9.52M	2.95%	9
2016 Q2	$7.78M	Buy	632,200 +165,175	+35%	+$2M	3.17%	6
2016 Q1	$4.72M	Buy	467,025 +67,025	+17%	+$787K	1.73%	21
2015 Q4	$9.02M	Buy	400,000 +275,000	+220%	+$5.63M	2.97%	10
2015 Q3	$2.07M	Buy	125,000 +25,000	+25%	+$501K	0.82%	37
2015 Q2	$2.25M	Buy	+100,000	New	+$2.47M	0.71%	45

Other funds holding OMED

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Iguana Healthcare Management's OMED Position: Q1 2018 in Review

Iguana Healthcare Management held its OncoMed Pharmaceuticals, Inc. (OMED) position steady in Q1 2018 at 150,000 shares worth $477K. The position accounts for 0.31% of the portfolio, ranked #59.

Iguana Healthcare Management first reported a position in OMED in Q2 2015 and has held it in 12 quarters since. The position peaked at $16.6M in Q3 2016. 66 funds tracked by Wall St. Rank hold OMED as of Q1 2018.

Iguana Healthcare Management held 150,000 shares of OncoMed Pharmaceuticals, Inc. worth $477K as of Q1 2018.
Iguana Healthcare Management left its OncoMed Pharmaceuticals, Inc. share count unchanged in Q1 2018.
OncoMed Pharmaceuticals, Inc. made up 0.31% of Iguana Healthcare Management's portfolio in Q1 2018, its #59 holding.
Iguana Healthcare Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q2 2015 and has held it in 12 quarters since.
Iguana Healthcare Management's OncoMed Pharmaceuticals, Inc. position peaked at $16.6M in Q3 2016.
66 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.